Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B

NCT01838655 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT01838655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 1/2
Overall status
Completed
Start date
April 16, 2013
Completion date
February 7, 2017
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albinism, vision loss